Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9251–9300 of 35188
On June 24, 2024, Mio Babic resigned from his role as a member of the Board of Directors of Edgio, Inc. (the “Company”), effective immediately.
On June 24 , 2024, the Board of Directors (the “Board”) of NextNav Inc. (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee of the Board, increased the size of the Board from six (6) directors to seven (7) directors and appointed Nicola Palmer as a director to fill the resulting vacancy with her term expiring at the Company’s 202 5 annual meeting of stockholders and until her successor has been elected and qualified, subject, however, to her earlier death, resignation, retirement, disqualification or removal.
the following directors resigned: Daniel Jones, Dr. Patrice M. Milos and Douglas Miscoll
the following directors resigned: Daniel Jones, Dr. Patrice M. Milos and Douglas Miscoll
Prateek Gattani, Chairman of the Board, Robert Machinist, Vice Chairman of the Board, Jeffrey Jagid, Jeffrey Kurtz and David Solimine were elected to the Board joining David Pfeffer
Prateek Gattani, Chairman of the Board, Robert Machinist, Vice Chairman of the Board, Jeffrey Jagid, Jeffrey Kurtz and David Solimine were elected to the Board joining David Pfeffer
Prateek Gattani, Chairman of the Board, Robert Machinist, Vice Chairman of the Board, Jeffrey Jagid, Jeffrey Kurtz and David Solimine were elected to the Board joining David Pfeffer
the following directors resigned: Daniel Jones, Dr. Patrice M. Milos and Douglas Miscoll
On June 21, 2024, Jeremy Miller and Tan Bien Kiat resigned as directors of the board
On June 21, 2024, Jeremy Miller and Tan Bien Kiat resigned as directors of the board
Effective June 25, 2024, the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”) increased the size of the Board to 12 directors and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Thomas N. Bohjalian to serve as a director.
On June 24, 2024, Oak Valley Bancorp issued a press release announcing that Ronald C. Marrtin will be retiring as a director of Oak Valley Bancorp and of its wholly owned subsidiary Oak Valley Community Bank effective June 30, 2024.
On June 23, 2024, the board of directors (the "Board") of ThredUp Inc. (the "Company") appointed Noam Paransky to the Board as a Class III director, effective as of June 23, 2024.
On June 19, 2024, Alexander Coleman notified the Board of Directors (the “Board”) of AST SpaceMobile, Inc. (the “Company”) of his decision to resign from the Board, effective on the same date.
On June 19, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Christopher Sambar as a director, effective June 20, 2024, to fill the vacancy on the Board created by Mr. Coleman’s resignation.
On June 24, 2024, CQENS Technologies Inc. (the “Company”) reported the death of Roger Nielsen, the secretary of the Company and a member of the Company’s board of directors.
On June 19, 2024, the Board of Directors (the “Board”) of PHINIA Inc. (the “Company”) increased the size of the Board from seven to eight members and elected Meggan M. Walsh to fill the resulting vacancy, each effective July 1, 2024 (the “Effective Date”).
Todd Klein did not stand for re-election at the annual meeting of stockholders held on June 20, 2024 (the “Annual Meeting”).
On June 20, 2024, the Board of Directors (the “Board”) of Frontier Group Holdings, Inc. (the “Company”) appointed Nancy Lipson to serve as a Class I director, effective as of July 1, 2024
Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.
Alexander Timm will replace Mr. Flanagan as lead independent director.
On June 21, 2024, the Board of Directors (the “Board”) of Coupang, Inc. (the “Company”) appointed Asha Sharma to serve as a director of the Board
On June 20, 2024, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved the appointment of Leah A. Solivan to serve as a director of the Company beginning June 24, 2024.
On June 21, 2024, the Board appointed Craig R. Jalbert, age 62, as the Company’s CEO, President, Treasurer and Secretary, and sole member of the Board.
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
On June 20, 2024, the board of directors (the “Board”) of bluebird bio, Inc. (the “Company”) appointed Michael Cloonan to the Board as a Class I director, effective June 20, 2024.
Effective June 24, 2024, The Goldman Sachs Group, Inc. (the Registrant) appointed John B. Hess as an independent member of the Registrant’s Board of Directors.
Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.
Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.
William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.
William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.
William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.
William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.
Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.
Richard A. Farmar, III, Andrew C. Holzwarth and Robert S. Janney, directors of Blue Ridge Bankshares, Inc. (the “Company”) and Blue Ridge Bank, National Association (the “Bank”), a wholly-owned subsidiary of the Company, each notified the Company and the Bank that they are voluntarily retiring from the Boards of Directors of the Company and the Bank effective as of the date of the Company’s 2024 annual meeting of shareholders
the Company announced that Mensel D. Dean, Jr. and Larry Dees, directors of the Company and the Bank, are retiring from the Boards of Directors of the Company and the Bank effective as of the date of the Annual Meeting pursuant to the Company’s mandatory director retirement age provision set forth in the Company’s Bylaws
Richard A. Farmar, III, Andrew C. Holzwarth and Robert S. Janney, directors of Blue Ridge Bankshares, Inc. (the “Company”) and Blue Ridge Bank, National Association (the “Bank”), a wholly-owned subsidiary of the Company, each notified the Company and the Bank that they are voluntarily retiring from the Boards of Directors of the Company and the Bank effective as of the date of the Company’s 2024 annual meeting of shareholders
the Company announced that Mensel D. Dean, Jr. and Larry Dees, directors of the Company and the Bank, are retiring from the Boards of Directors of the Company and the Bank effective as of the date of the Annual Meeting pursuant to the Company’s mandatory director retirement age provision set forth in the Company’s Bylaws
Richard A. Farmar, III, Andrew C. Holzwarth and Robert S. Janney, directors of Blue Ridge Bankshares, Inc. (the “Company”) and Blue Ridge Bank, National Association (the “Bank”), a wholly-owned subsidiary of the Company, each notified the Company and the Bank that they are voluntarily retiring from the Boards of Directors of the Company and the Bank effective as of the date of the Company’s 2024 annual meeting of shareholders
On June 19, 2024, Dr. Moncef Slaoui, Ph.D., agreed to serve as a member of the Board of Directors
On June 24, 2024, Invesco Mortgage Capital Inc. (the "Company") increased the size of its Board of Directors (the “Board”) from seven to eight directors and appointed W. Wesley McMullan to serve as a director of the Company effective as of that date.
On June 21, 2024, the board of directors (the “Board”) of Contineum Therapeutics, Inc. (the “Company”) appointed Sarah Boyce as a member of its Board, effective June 24, 2024.
On June 18, 2024, James Hansen, a member of the Board of Directors (the “Board”) of SideChannel, Inc. (the “Company”) resigned from his position on the Board.
the Board appointed Ms. McBane to serve as a Class B director on the Board
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.